Past, present, and future of radiotherapy for the benefit of patients

J Thariat, JM Hannoun-Levi, A Sun Myint… - Nature reviews Clinical …, 2013 - nature.com
Radiotherapy has been driven by constant technological advances since the discovery of X-rays
in 1895. Radiotherapy aims to sculpt the optimal isodose on the tumour volume while …

Oral complications of cancer and cancer therapy: from cancer treatment to survivorship

JB Epstein, J Thariat, RJ Bensadoun… - CA: a cancer journal …, 2012 - Wiley Online Library
Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …

[HTML][HTML] Combining PARP inhibition, radiation, and immunotherapy: A possible strategy to improve the treatment of cancer?

M Césaire, J Thariat, SM Candéias, D Stefan… - International Journal of …, 2018 - mdpi.com
Immunotherapy has revolutionized the practice of oncology, improving survival in certain
groups of patients with cancer. Immunotherapy can synergize with radiation therapy, increase …

[HTML][HTML] New concepts in the diagnosis and management of choroidal metastases

…, C Mosci, JP Caujolle, L Kodjikian, J Thariat - Progress in retinal and …, 2019 - Elsevier
The most frequent site of ocular metastasis is the choroid. The occurrence of choroidal
metastases has increased steadily due to the longer survival of metastatic patients and the …

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma …

S Bonvalot, PL Rutkowski, J Thariat, S Carrère… - The Lancet …, 2019 - thelancet.com
Background Pathological complete response to preoperative treatment in adults with soft-tissue
sarcoma can be achieved in only a few patients receiving radiotherapy. This phase 2–3 …

[HTML][HTML] Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement

…, S Porceddu, YL Soong, Y Sun, J Thariat… - International Journal of …, 2020 - Elsevier
Purpose Because of the unprecedented disruption of health care services caused by the
COVID-19 pandemic, the American Society of Radiation Oncology (ASTRO) and the European …

[HTML][HTML] Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment …

…, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat… - European Journal of …, 2020 - Elsevier
Background Cancer patients are thought to have an increased risk of developing severe
Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this work, …

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer

EF Lartigau, E Tresch, J Thariat, P Graff… - Radiotherapy and …, 2013 - Elsevier
Purpose Recurrent head and neck cancer is associated to a poor survival prognosis. A high
toxicity rate is demonstrated when surgery and/or radiotherapy and/or chemotherapy are …

[HTML][HTML] Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group

…, F Collin, JY Blay, A Le Cesne, J Thariat - European Journal of …, 2014 - Elsevier
Introduction Primary cardiac sarcomas (PCS) are rare tumours of dismal prognosis. Methods
Data of 124 patients with PCS referred to institutions of the French Sarcoma Group (FSG) …

Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study

A Benlyazid, J Thariat, S Temam… - … –Head & Neck …, 2010 - jamanetwork.com
Objective To report patterns of failure according to treatment modality, with an emphasis on
the role of postoperative radiotherapy in patients with localized head and neck mucosal …